about
Vitamin B and its derivatives for diabetic kidney diseaseChinese medicinal herbs for treating diabetic kidney diseaseVitamin B and/or its derivatives for diabetic kidney diseaseChinese medicinal herbs for treating diabetic kidney diseaseAdvanced glycation end products and diabetic complicationsNull association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects.Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic RatsAssociation of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuriaLong-term renal changes in the liver-specific glucokinase knockout mouse: implications for renal disease in maturity-onset diabetes of the young 2.Angiotensin (1-7)/Mas receptor axis activation ameliorates the changes in fatty acid composition in diabetic rats with nephropathy.Sodium and Its Role in Cardiovascular Disease - The Debate Continues.The role of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 in diabetic nephropathy.Differential effects of Smad3 targeting in a murine model of chronic kidney diseaseDown-regulated miR-15a mediates the epithelial-mesenchymal transition in renal tubular epithelial cells promoted by high glucose.Telmisartan decreases microalbuminuria in patients with type 2 diabetes mellitus following coronary artery bypass grafting.A case of "hidden" diabetic nephropathy diagnosed by a combination of renal biopsy findings and continuous glucose monitoring system.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy.Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients.Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53.
P2860
Q24186641-B9A41A89-4A5D-4147-933F-DA6CD5E9C4FAQ24192995-81736367-16D2-42B2-B993-3E245EC0B26EQ24236375-2BC79ACC-F1E5-43DD-947E-C69F115E3C43Q24243310-B62AEB11-D22E-4E96-94CF-79AD3A2FDF5FQ27687501-0146C522-9C70-46F6-B907-B312EFC8AE0DQ34204848-B4C49441-B577-4E62-AD36-6CE76A519C3FQ35689644-34677DF6-9CF6-4231-B311-E8DD5BAA9B5BQ36292425-CE219974-53D2-4E02-B208-39D3391DFE2BQ36550886-CE244CDD-9EE5-4FCE-9775-01E5F916444EQ36721369-EB0BDA42-ABA9-42C4-A2CA-97D979F4F424Q36846856-111C63AB-8471-42B9-8E61-B0D97CFD233FQ36890435-75F70B73-FF52-41F5-A472-83D9FEFEBAF3Q37528633-B51C2E22-E960-401B-87ED-BF6C1139209CQ37974594-1F4489EA-C826-4C41-A955-E4685EE7BB85Q38568865-1F74BDBF-9E73-40A1-8737-0C246FC7E716Q38965204-E48E554D-9336-434F-9DF0-F53620D9CA4EQ41426776-5B26A48B-C8B5-4217-95B4-034ABD83C7DBQ42289875-FB7FADD5-4C51-4BD1-9B48-0F8D188F4D4BQ42876331-81EE2609-8D3A-4A6B-BF56-8BF0EB3882D4Q46650693-D583ECA9-9174-4792-ABAF-D4909C77AABAQ50643798-ABF169A2-93F2-4862-914A-E44395FDBF05Q51239496-04F08D36-88B5-4215-AA4D-FE7CBF79C284
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Recent advances in diabetic nephropathy
@ast
Recent advances in diabetic nephropathy
@en
type
label
Recent advances in diabetic nephropathy
@ast
Recent advances in diabetic nephropathy
@en
prefLabel
Recent advances in diabetic nephropathy
@ast
Recent advances in diabetic nephropathy
@en
P2860
P356
P1476
Recent advances in diabetic nephropathy
@en
P2093
Marshall SM
P2860
P304
P356
10.1136/PGMJ.2004.021287
P407
P577
2004-11-01T00:00:00Z